Radiotherapy and Immunotherapy at a Crossroads: Mechanistic Foundations, Emerging Evidence, and a New Horizon for Precision Oncology
Journal of Personalized Medicine · 08.05.2026 · 16 (5) · 256
DOI: 10.3390/jpm16050256 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Personalized Medicine, online erschienen am 08.05.2026. Verfasst von Gianluca Ferini und 1 weiteren Autor:innen. Beteiligte Einrichtung: REM Radioterapia srl, 95029 Catania, Italy. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The trajectory of modern oncology is increasingly defined by the convergence of two therapeutic paradigms that were once considered only marginally related: radiotherapy and immunotherapy [...]
Autor:innen und Institutionen
- REM Radioterapia srl, 95029 Catania, Italy.
- Department of Medicine and Surgery, University Kore of Enna, 94100 Enna, Italy.
- Mediterranean Institute of Oncology, 95029 Catania, Italy.
ORCID-Profile: Gianluca Ferini, Stefano Forte
Zitieren
APA
Ferini, G., & Forte, S. (2026). Radiotherapy and Immunotherapy at a Crossroads: Mechanistic Foundations, Emerging Evidence, and a New Horizon for Precision Oncology. Journal of Personalized Medicine, 16(5), 256. https://doi.org/10.3390/jpm16050256
Vancouver
Ferini G, Forte S. Radiotherapy and Immunotherapy at a Crossroads: Mechanistic Foundations, Emerging Evidence, and a New Horizon for Precision Oncology. Journal of Personalized Medicine. 2026;16(5):256. doi:10.3390/jpm16050256
BibTeX
@article{Ferini2026,
author = {Ferini, Gianluca and Forte, Stefano},
title = {Radiotherapy and Immunotherapy at a Crossroads: Mechanistic Foundations, Emerging Evidence, and a New Horizon for Precision Oncology},
journal = {Journal of Personalized Medicine},
year = {2026},
volume = {16},
number = {5},
pages = {256},
doi = {10.3390/jpm16050256}
}
EUVIMED